A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines

Author:

Tiecco Giorgio,Degli Antoni Melania,Storti Samuele,Marchese ValentinaORCID,Focà EmanueleORCID,Torti CarloORCID,Castelli Francesco,Quiros-Roldan EugeniaORCID

Abstract

In 2021 the scientific community’s efforts have been focused on solving the back-breaking challenge of the COVID-19 pandemic, but sexually transmitted infections (STI) are still one of the most common global health problems. Syphilis is a systemic disease caused by the spirochaete Treponema pallidum (TP) and is one of the oldest known diseases. Its incidence has increased in the last few years and syphilis still remains a contemporary plague that continues to afflict millions of people worldwide. Despite research improvements, syphilis pathogenesis is not completely clear; clinical presentation is very heterogeneous and the diagnosis can sometimes be difficult. Furthermore, few therapeutic options are available, and a vaccine has not been found yet. In this review, we describe the most recent evidence concerning the clinical manifestation, diagnosis, treatment and vaccine prospectives for this disease.

Publisher

MDPI AG

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy

Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Syphilis;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Investigation and application of a classical piecewise hybrid with a fractional derivative for the epidemic model: Dynamical transmission and modeling;PLOS ONE;2024-08-29

3. Psycho-sexological impact(s) of syphilis among infected persons;Journal of Sexual Health Psychology;2024-08-01

4. Decoding and Unravelling Mpox, Herpes, and Syphilis Infections: A State of Art Review;Current Pharmaceutical Biotechnology;2024-07-19

5. Contact-tracing outcomes among male syphilis patients at a tertiary care hospital in North Eastern India;IP Indian Journal of Clinical and Experimental Dermatology;2024-06-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3